De Felice M, Guardiola J, Malorni M C, Klopotowski T, Iaccarino M
J Bacteriol. 1974 Dec;120(3):1058-67. doi: 10.1128/jb.120.3.1058-1067.1974.
Three mutations (ilvH611, ilvH612, and ilvH613) are described which make Escherichia coli K-12 resistant to valine inhibition and are located near leu. The expression of the ilv genes appears to be normal in these mutants since the isoleucine-valine biosynthetic enzymes are not derepressed relative to the wild type. The intracellular concentration of valine is, however, higher in the mutants than in the isogenic ilvH(+) strain. These mutants also excrete valine, probably because of the high intracellular concentration of this amino acid. The pool size of valine is regulated independently from that of isoleucine and leucine. The increased intracellular concentration of valine is due to a decreased feedback inhibition that valine exerts on its own biosynthetic pathway. In fact, acetolactate synthase activity assayed in extracts of ilvH612 and ilvH613 mutants is more resistant to valine inhibition than the activity assayed in the ilvH(+) isogenic strain. Two forms of acetolactate synthase activity can be separated from these extracts by adsorption and elution on hydroxylapatite. One of them is as sensitive to valine inhibition as that of the wild type, the other is more resistant to valine inhibition.
描述了三种突变(ilvH611、ilvH612和ilvH613),它们使大肠杆菌K-12对缬氨酸抑制产生抗性,且位于leu附近。这些突变体中ilv基因的表达似乎正常,因为异亮氨酸-缬氨酸生物合成酶相对于野生型并未去阻遏。然而,突变体中缬氨酸的细胞内浓度高于同基因的ilvH(+)菌株。这些突变体也会分泌缬氨酸,可能是由于这种氨基酸在细胞内的高浓度。缬氨酸的库大小与异亮氨酸和亮氨酸的库大小独立调节。细胞内缬氨酸浓度的增加是由于缬氨酸对其自身生物合成途径的反馈抑制作用减弱。事实上,在ilvH612和ilvH613突变体提取物中测定的乙酰乳酸合酶活性比在同基因的ilvH(+)菌株中测定的活性更能抵抗缬氨酸抑制。通过在羟基磷灰石上吸附和洗脱,可以从这些提取物中分离出两种形式的乙酰乳酸合酶活性。其中一种对缬氨酸抑制的敏感性与野生型相同,另一种对缬氨酸抑制更具抗性。